Over the past 12‑18 months the Montmorillonite Bentonite Clay market has seen a wave of strategic activity that reshapes supply chains and product portfolios. In Q2 2024, EcoMinerals Ltd. formed a joint venture with Japanese biotech firm Kirin Bio to co‑develop high‑purity clay for pharmaceutical binders, accelerating time‑to‑market for oral solid dosage forms, while meanwhile, Bentonite Holdings completed its acquisition of Australian miner RedRock Resources, adding 45 kt/yr of low‑iron clay and expanding its footprint into the Asia‑Pacific region. In August 2023, GreenEarth Materials launched a nano‑engineered “Super‑Absorb” line that integrates modified montmorillonite with biodegradable polymers, targeting agricultural water‑retention applications. Regulatory momentum also grew: the EU revised its REACH guidelines in early 2024, granting expedited review for montmorillonite‑based adsorbents used in wastewater treatment, which is prompting European processors to upscale capacity. Consumer demand is shifting toward clean‑label cosmetics, driving a 22 % rise in premium cosmetic‑grade clay shipments. Finally, a $45 million Series B round led by CleanTech Ventures enabled TerraClay to double its North‑American production site, underscoring the bullish outlook for the Montmorillonite Bentonite Clay industry trends.